Suggestions
Share
Journal Information
Vol. 78. Issue S2.
Pages 195-204 (November - December 2002)
Vol. 78. Issue S2.
Pages 195-204 (November - December 2002)
Full text access
Vacinas e o trato respiratório - o que devemos saber?
Visits
2618
Calil K. Farhata, Otávio Augusto Leite Cintrab, Miguel W. Tregnaghic
a Professor Titular do Departamento de Pediatria da Universidade Federal de São Paulo - Escola Paulista de Medicina (UNIFESP-EPM). Professor Titular de Moléstias Infecciosas da Faculdade de Medicina de Marília.
b Professor Assistente do Serviço de Infectologia Pediátrica do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto - Universidade de São Paulo (FMRP - USP). Doutor em Pediatria pela FMRP-USP.
c Professor de Infectologia. Especialista em Infectologia Pediátrica. Diretor do Centro de Desenvolvimento de Projetos Avançados. Chefe do Departamento de Pediatria do Hospital Infantil de Córdoba, Argentina.
This item has received
Article information
Special issue
This article is part of special issue:
Vol. 78. Issue S2
More info
Abstract
Objective

this article aims at presenting a review of the main vaccines used in the pediatric population with direct impact on the prevention of infectious processes of the respiratory tract in children.

Sources

data from articles published in national and international scientific journals. The data were selected by means of direct search or search in the Lilacs and Medline databases.

Summary of the findings

this article was structured in topics, presenting issues related to immunization against frequent pathogens of the respiratory tract in human beings: Haemophilus influenza, influenza virus, respiratory syncytial virus and Streptococcus pneumoniae.

onclusions

the prevention of respiratory diseases through immunization is one of the main measures for the control of respiratory infection. These new vaccines, especially against Haemophilus influenza, have been available for some years with acknowledged efficacy. Now, the vaccine against Streptococcus pneumoniae (heptavalent vaccine) leads to a new perspective towards the management of respiratory diseases in children. In risk populations, the control of viral diseases through immunization, actively against the influenza virus and passively against the syncytial respiratory virus, is also an efficient measure to reduce respiratory disease.

Full text is only available in PDF
Download PDF
Idiomas
Jornal de Pediatria (English Edition)
Article options
Tools